GoodRx Holdings, Inc.

GDRX - CIK 0001809519

Market cap$1.01 B

Rank#2632

SEC filings547

GoodRx Holdings, Inc. trades as GDRX and has a market capitalization of $1.01 B, making it the #2632 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $796.85M, up 0.6% from the prior year and net income of $30.40M. This page tracks GoodRx Holdings, Inc. through 547 SEC filings, with financial statements and metrics updated as new reports are filed.

Key metrics

Revenue (latest FY)$796.85MFY 2025

Net income (latest FY)$30.40MFY 2025

Operating cash flow (latest FY)$167.90MFY 2025

Total assets (latest FY)$1.40BFY 2025

Net margin3.8%latest FY

Financial performance

Over the last 7 fiscal years GoodRx Holdings, Inc.'s revenue grew from $249.52M to $796.85M, a compound annual growth rate of 18.0%. Net profit margin compressed from 17.6% to 3.8% over the same period - every figure below comes from the company's audited annual filings.

GDRX annual revenueView details

Key statistics

Market cap: $1.01 B
P/E ratio (trailing FY): 33.2
EPS (diluted)FY 2025: $0.09
Total equityas of 2026-03-31: $621.99M
Return on equity: 4.9%
Long-term debtas of 2026-03-31: $482.42M
Cash & equivalentsas of 2026-03-31: $235.71M
Dividends paidFY 2018: $1.35B

Latest filings

Filing	Type	Filed
Insider trade	4	2026-05-15
Insider trade	4	2026-05-15
Insider sale notice	144	2026-05-13
Insider trade	4	2026-05-12
Quarterly report	10-Q	2026-05-06
Major company event	8-K	2026-05-06
New insider ownership	3	2026-05-01
Annual report to shareholders	ARS	2026-04-29

Browse the full filing history (547 filings)

Recent press releases

GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs2026-05-27
GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs - GoodRx
GoodRx Reports First Quarter 2026 Results2026-05-06
GoodRx Reports First Quarter 2026 Results - GoodRx
GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients2026-05-01
GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients - GoodRx
GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call2026-04-17
GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call - GoodRx
GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price2026-04-15
GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price - GoodRx

Similar companies

The largest companies sharing GoodRx Holdings, Inc.'s SEC industry classification (services-computer processing & data preparation).

ADPAutomatic Data Processing, Inc.$92.35 B GDRX vs ADP

RDDTReddit, Inc.$33.78 B GDRX vs RDDT

WDAYWorkday, Inc.$30.24 B GDRX vs WDAY

VRSKVerisk Analytics$23.99 B GDRX vs VRSK

TOSTToast, Inc.$15.12 B GDRX vs TOST

Frequently asked questions

What is GoodRx Holdings, Inc.'s market cap?

GoodRx Holdings, Inc. (GDRX) has a market capitalization of $1.01 B as of 2026-05-29, ranking #2632 among US-listed companies.

How much revenue does GoodRx Holdings, Inc. make?

GoodRx Holdings, Inc. reported revenue of $796.85M for fiscal year 2025, an increase of 0.6% year over year.

Is GoodRx Holdings, Inc. profitable?

Yes. GoodRx Holdings, Inc. reported net income of $30.40M in its latest fiscal year.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.